Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 10/20 | 0.44 |
| ▸ | SOAT2 | O75908 | 4/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 4/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6797773 | 0.93 | SOAT2 (0.48) | NMBRSOAT2SOAT1 | |
| SCHEMBL6801610 | 0.90 | SOAT2 (0.49) | NMBRSOAT2SOAT1 | |
| SCHEMBL6203402 | 0.83 | PPARG (0.46) | FFAR1LTA4H | |
| SCHEMBL6801616 | 0.80 | YAP1 (0.42) | FFAR1LTA4H | |
| SCHEMBL9680219 | 0.74 | MAOB (0.52) | SOAT2SOAT1FFAR1LTA4H | |
| SCHEMBL9679273 | 0.74 | LNPEP (0.58) | SOAT2SOAT1FFAR1LTA4H | |
| SCHEMBL6804298 | 0.73 | CYP1A2 (0.45) | — | |
| SCHEMBL6203424 | 0.73 | PPARG (0.41) | NMBR | |
| SCHEMBL9818605 | 0.73 | SOAT1 (0.66) | NMBRSOAT2SOAT1 | |
| SCHEMBL9679658 | 0.72 | MMP9 (0.55) | SOAT2SOAT1FFAR1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063643-A1 | Bombesin antagonists | PFIZER INC. | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063643-A1 | Bombesin antagonists | BRS3, NPSR1, GNRHR | NMBR 211/4885SOAT2 3379/4885SOAT1 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.